Search results
Apr 13, 2023 · The Access to COVID-19 Tools (ACT) Accelerator, is a new, groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
- What is The Act Accelerator
The Access to COVID-19 Tools (ACT) Accelerator, is a new,...
- Covax
The ACT Accelerator is a ground-breaking global...
- Country Readiness and Delivery
The Country Readiness and Delivery (CRD) workstream was part...
- Frequently Asked Questions
What is the ACT-Accelerator? The Access to COVID-19 Tools...
- ACT-A HSRC
The Access to COVID-19 Tools Accelerator (ACT-A) is a global...
- What is The Act Accelerator
The Access to COVID-19 Tools (ACT) Accelerator, is a new, groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
The Access to COVID-19 Tools Accelerator (ACT Accelerator or ACT-A), or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. [1]
What is the ACT-Accelerator? The Access to COVID-19 Tools (ACT) Accelerator is the world’s most comprehensive end-to-end solution to ending the acute phase of the devastating COVID-19 pandemic. It brings together governments, health organizations, scientists, businesses, civil society, and philanthropists to accelerate the development ...
The ACT-Accelerator combines public and private sector expertise and institutions from around the world to fast-track the development and equitable distribution of COVID-19 diagnostics,...
Jan 29, 2022 · To jumpstart a more collaborative and fairer pandemic response, several existing organisations created the Access to COVID-19 Tools-Accelerator (ACT-A) to work collectively towards innovation and globally equitable access to vaccines, therapeutics, and diagnostics.
Aug 4, 2021 · The Access to COVID-19 Tools Accelerator (ACT-A) is a global collaboration to accelerate the development, production, and equitable access to COVID-19 tools (diagnostics, therapeutics, and vaccines).